A new innovative method for diabetes treatment, the artificial pancreas system

Projektinformationen

MedicSen

ID Finanzhilfevereinbarung: 781917

DOI 10.3030/781917

Abgeschlossenes Projekt

EK-Unterschriftsdatum 14 Juli 2017

Startdatum 1 August 2017

Enddatum 31 Januar 2018

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

MEDICSENSORS SL
Spain

Ziel

There is a very well-known worldwide problem in the management of chronic diseases and high costs associated to its control resulting in a poor service. Different studies prove how m-health (telemonitoring, apps and sensors) facilitate better understanding and management of the disease. Diabetes is one of the major examples of these facts.

MEDICSEN has patented an innovative methodology to personalize the management of chronic diseases that will reduce its socio-economic impact. MEDICSEN is based on continuous monitoring, daily friendly interaction with the patient, and personalized therapies through needle-free drug dispenser.

MEDICSEN aim to promote the necessary change in the structure of treatment of chronic diseases, leading the transformation movement towards personalized telemedicine and therefore improving control and reducing spending on such common diseases as cardiovascular, diabetes or obesity. The first case study of technological and commercial application for this general system environment is performed for diabetes but keeping the intention of adapting it to other chronic diseases in the future. Then, MEDICSEN is responsible for modifying the patient glucose curve analysis according to his/her usual behaviour and the value of various parameters (such as temperature, blood pressure or heart rate), thus adjusting the treatment specifically for each individual context and for each moment so the patient can release his/her mind from the dose calculations.

The project has a relevant European Dimension. Chronic diseases represent a significant burden on individuals and healthcare systems in the European Union and beyond. The accomplishment of the objectives will result in an EBITDA of 102M€ in five years after put into market MEDICSEN (from € 0.7M in 2017) and an increase of the company size (from 7 to 100 employees).

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › neurology › epilepsy
• medical and health sciences › clinical medicine › endocrinology › diabetes
• medical and health sciences › medical biotechnology › tissue engineering › artificial pancreas
• natural sciences › computer and information sciences › computer security
• medical and health sciences › health sciences › nutrition › obesity

Programm/Programme

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
• H2020-EU.3.1.4. - Active ageing and self-management of health
• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
• H2020-EU.3.1.6. - Health care provision and integrated care

Thema/Themen

• SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2016-2017

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

MEDICSENSORS SL

• Netto-EU-Beitrag: € 50 000,00
• Adresse: CALLE NUNEZ DE BALBOA, NUM. 35 PLANTA 6 ; 28001 Madrid ; Spanien
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Comunidad de Madrid › Comunidad de Madrid › Madrid
• Region: Comunidad de Madrid › Comunidad de Madrid › Madrid
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00